Prediction of in vivo tissue distribution from in vitro data.: 2.: Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids

被引:17
作者
Ballard, P [1 ]
Leahy, DE
Rowland, M
机构
[1] AstraZeneca, Discovery DMPK, Alderley Pl SK10 4TG, Cheshire, England
[2] Cyprotex, Macclesfield SK10 2DR, Cheshire, England
[3] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England
关键词
in vitro-in vivo correlation; barbiturate; tissue distribution; pharmacokinetics;
D O I
10.1023/A:1023912318133
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To evaluate the ability to determine accurate in vivo tissue-to-unbound plasma distribution coefficients ( Kpu(e)) from in vitro data. Methods. Fresh pieces of fifteen rat tissues/organs were incubated at 37 degreesC with a homologous series of nine barbiturates covering a wide range of lipophilicity ( Log P 0.02 to 4.13). Steady-state in vivo Kpue values were estimated from the tissue and plasma concentrations following simultaneous dosing by constant rate i.v. infusion of all nine barbiturates. Drug concentrations in the tissues and media were determined by HPLC with UV or mass spectrometric detection. Results. The pharmacokinetics of the barbiturate series following constant rate i.v. infusion indicated a range of clearance (0.49 to 30 ml.min(-1). kg(-1)) and volume of distribution at steady state ( 0.51 to 1.9 l.kg(-1)) values. Good agreement was observed between the in vitro and in vivo Kpu values, although for the most lipophilic barbiturates the in vitro data underpredicted the in vivo tissue distribution for all tissues. Conclusions. The in vitro system for predicting the extent of in vivo tissue distribution works well for compounds of widely differing lipophilicity, although for the most lipophilic drugs it may result in an underprediction of in vivo values.
引用
收藏
页码:864 / 872
页数:9
相关论文
共 31 条
[1]   Prediction of in vivo tissue distribution from in vitro data 1. Experiments with markers of aqueous spaces [J].
Ballard, P ;
Leahy, DE ;
Rowland, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :660-663
[2]  
BALLARD P, PHARM RES, V20, P864
[3]  
BENAREGGI A, 1991, J PHARMACOKINET BIOP, V19, P21
[4]   USE OF TISSUE SLICE TECHNIQUE FOR EVALUATION OF RENAL TRANSPORT PROCESSES [J].
BERNDT, WO .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1976, 15 (JUN) :73-88
[5]   BINDING OF BASIC AND ACIDIC DRUGS TO RAT TISSUE SUBCELLULAR-FRACTIONS [J].
BICKEL, MH ;
STEELE, JW .
CHEMICO-BIOLOGICAL INTERACTIONS, 1974, 8 (03) :151-162
[6]   CHARACTERIZATION OF DRUG DISTRIBUTION AND BINDING COMPETITION BY 2-CHAMBER AND MULTICHAMBER DISTRIBUTION DIALYSIS [J].
BICKEL, MH ;
RAAFLAUB, RM ;
HELLMULLER, M ;
STAUFFER, EJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (01) :68-74
[7]   PRELIMINARY MODEL FOR METHOTREXATE PHARMACOKINETICS [J].
BISCHOFF, KB ;
DEDRICK, RL ;
ZAHARKO, DS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (02) :149-+
[8]  
BLAKEY G, 1993, THESIS MANCHESTER
[9]   Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat [J].
Blakey, GE ;
Nestorov, IA ;
Arundel, PA ;
Aarons, LJ ;
Rowland, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (03) :277-312
[10]   ESTIMATION OF TISSUE-TO-PLASMA PARTITION-COEFFICIENTS USED IN PHYSIOLOGICAL PHARMACOKINETIC MODELS [J].
CHEN, HSG ;
GROSS, JF .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :117-125